evolcSign inStart free
Menu

Renaissance Pharma

Develops an investigational anti-GD2 antibody immunotherapy for children with high-risk neuroblastoma

Surrey, United KingdomFounded 2022renaissancepharma.co.ukWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2022
  • New on EvolcAdded 2026-10-30

About Renaissance Pharma

Renaissance Pharma Limited is a development-stage pharmaceutical company focused on improving treatment options in rare paediatric diseases. Its lead candidate, Daretabart (hu14.18K322A), is a humanised anti-GD2 antibody immunotherapy being evaluated in clinical studies for high-risk neuroblastoma. The compound is investigational and not approved in the UK, EU or other markets.

The company is part of Essential Pharma, an international specialty pharma group. Essential Pharma completed the acquisition of the entire issued share capital of Renaissance Pharma in April 2024. Daretabart was in-licensed in 2023 under an exclusive license agreement with St. Jude Children's Hospital. The target patients are children with high-risk neuroblastoma.

The company was founded in December 2022 and is registered in Surrey, United Kingdom. In April 2026 it announced that the US Food and Drug Administration granted Fast Track Designation and IND clearance for Daretabart in high-risk neuroblastoma.

Product: Daretabart (hu14.18K322A), an investigational humanised anti-GD2 antibody immunotherapy for high-risk neuroblastoma.

Jobs at Renaissance Pharma

No open positions listed right now.

More biotech & pharma companies

  • Reneuron Group

    Exosome-based drug delivery platform built from engineered stem cell lines, for developers of targeted therapeutics
    Weybridge, United KingdomBiotech & pharmaFounded 2005
    New on Evolc

  • Resolution Therapeutics

    Develops regenerative macrophage cell therapies for patients with inflammatory and fibrotic diseases
    London, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

  • Richmond Pharmacology

    Early-phase clinical trial CRO in London running first-in-human and gene-editing studies for pharma and biotech sponsors
    London, United KingdomBiotech & pharmaFounded 20013 open jobs
    New on EvolcRemote-friendly

  • Rinri Therapeutics

    Develops regenerative cell therapies for people with sensorineural hearing loss
    Sheffield, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • RoukenBio

    Preclinical immunology research and assay services for biotechnology and drug development companies
    Motherwell, United KingdomBiotech & pharmaFounded 20151 open job
    Remote-friendlySalary transparent

  • Rxbiologics

    Antibody discovery services for biologics drug discovery programmes, built on a proprietary human antibody library
    Cambridge, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • CookieYes
  • Matomo
  • Squarespace